1QSJ image
Entry Detail
PDB ID:
1QSJ
Keywords:
Title:
N-TERMINALLY TRUNCATED C3DG FRAGMENT
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
1999-06-22
Release Date:
2000-07-31
Method Details:
Experimental Method:
Resolution:
1.90 Å
R-Value Free:
0.25
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:COMPLEMENT C3 PRECURSOR
Mutations:M1081Y, W1082V, S1085V
Chain IDs:A, B, C, D
Chain Length:277
Number of Molecules:4
Biological Source:Rattus norvegicus
Primary Citation
Structure at 1.44 A resolution of an N-terminally truncated form of the rat serum complement C3d fragment.
Biochim.Biophys.Acta 1478 232 238 (2000)
PMID: 10825534 DOI: 10.1016/S0167-4838(00)00040-6

Abstact

Complement component C3 plays a key role in the complement-mediated immune defence, and occupies a central position within the complement cascade system. One of its degradation products, C3dg, was purified from rat serum and crystallised in two different crystal forms as N-terminally truncated fragment. Despite the truncation and the lack of a significant portion of the N-terminus as compared to C3d, the structure of the fragment is highly similar to that of recombinant human C3d (Nagar et al., Science 280 (1998) 1277-1281). Structural details of the reactive site have been obtained, suggesting a possible mode of thioester bond formation between Cys-1010 and Gln-1013 and thioester bond cleavage in the transacylation reaction involving His-1126. The truncation at the N-terminus of C3d leads to the exposure of a surface of the molecule that favours dimerisation, so that in both crystal forms, the fragment is present as a dimer, with monomers related by a two-fold axis.

Legend

Protein

Chemical

Disease

Primary Citation of related structures